Clinical Trials Browser

Phase 2 × Leukemia, Lymphocytic, Chronic, B-Cell × NVP-BKM120 × Clear all

NCT02340780 2023-08-22

Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia

Phase 2 Completed

14 enrolled 9 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell